Bicalutamide in the treatment of advanced prostatic carcinoma: A phase II multicenter trial

Urology

Volumn 47, Issue 1 SUPPL. 1, 1996, Pages 33-37

  Soloway, Mark S ^a   Schellhammer, Paul F ^b   Smith, Joseph A ^c   Chodak, Gerald W ^d   Kennealey, Gerard T ^e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e Zeneca Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTIANDROGEN; BICALUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ASTHENIA; BONE PAIN; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DYSPNEA; EDEMA; GASTROINTESTINAL TOXICITY; GYNECOMASTIA; HEMATURIA; HOT FLUSH; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MULTICENTER STUDY; NAUSEA; NOCTURIA; PELVIS PAIN SYNDROME; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; RASH; URINE INCONTINENCE;

ACID PHOSPHATASE; ADULT; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANILIDES; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0029565070     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(96)80006-9     Document Type: Article

References (11)

1. Kennealey GT, and Furr BJA: Use of the nonsteroidal antiandrogen Casodex in advanced prostatic carcinoma. Urol Clin North Am 18: 99-110, 1991.
2. Furr BJA: Casodex: Preclinical studies. Eur Urol 18: 2-9, 1990.
3. Cockshott ID, Cooper KJ, Seetmore DS, Blacklock NJ, and Denis L: The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing. Eur Urol 18 (suppl):10-17, 1990.
4. Denis L: A new non-steroidal anti-androgen: therapeutic progress in urological cancers. Clin Biol Res 303: 95-103, 1989.
5. Peeling WB: Phase III studies to compare goserelin (ZOLADEX) with orchiectomy and with diethylstilbestrol in the treatment of prostatic carcinoma. Urology 33 (suppl):45-52, 1989.
6. 2 prostatic cancer. Cancer 70: 2302-2309, 1992.
7. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway MS, and Moinuddin M: Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61: 195-202, 1988.
8. 2) prostate cancer. JAMA 265: 618-621, 1991.
9. Hickey D, Todd B, and Soloway MS: Pre-treatment testosterone levels: significance in androgen deprivation therapy. J Urol, 136: 1038-1040, 1986.
10. 2 prostate cancer treated with a pure nonsteroidal anti-androgen. Cancer 72: 1286-1290, 1993.
11. Ojasoo J: Nilutamide. Drugs Future 12: 763, 1987.